510(k) device
Omnipod 6 algorithm
Insulet Corporation · Interoperable Automated Glycemic Controller (QJI, Class II) · First FDA decision Jun 29, 2026, newest Jun 29, 2026Diabetes
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "Omnipod 6 algorithm"
MAUDE reports
0
Brand "Omnipod 6 algorithm", since 2015
PubMed studies
0
Mentioning "Omnipod 6 algorithm"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Omnipod 6 algorithm
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Omnipod 6 algorithm", any status and sponsor, newest update first.
- Outpatient Pramlintide StudyNot yet recruiting
Oregon Health and Science UniversityAcademic, hospital or other
NCT07914621 · 26 participants (planned) · Start Nov 2, 2026 · Primary completion Jan 31, 2027
Device: Single-hormone automated insulin delivery system; Dual-hormone automated insulin and pramlintide delivery system · For: Type 1 Diabetes
Oregon Health and Science UniversityAcademic, hospital or other
NCT06422325 · 33 participants · Start Jul 12, 2024 · Primary completion Jan 4, 2025
Device: MPC closed-loop system in insulin only mode; MPC closed-loop system in insulin/pramlintide mode · For: Type 1 Diabetes
Sites: Portland, Oregon
Sansum Diabetes Research InstituteAcademic, hospital or other
NCT01874392 · 9 participants · Start Oct 2012 · Primary completion Jun 2013
Device: Artificial Pancreas (AP) device (APS©) · For: Type 1 Diabetes Mellitus
Sites: Santa Barbara, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Omnipod 6 algorithm", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QJI
5,524 reports: 3,680 malfunction, 1,836 injury, 4 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Omnipod 6 algorithm"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QJI.
- SmartGuard TechnologyMedtronic MiniMed · 510(k) 2026
- SmartAdjust TechnologyInsulet Corporation · 510(k) 2024
- iLet Dosing Decision SoftwareBeta Bionics, Inc. · 510(k) 2026
- Control-IQ+ technologyTandem Diabetes Care, Inc. · 510(k) 2026
- Control-IQ TechnologyTandem Diabetes Care, Inc. · De Novo 2023
- twiist Loop AlgorithmDeka Research and Development Corp. · 510(k) 2026
- iOS CamAPS FXCamDiab · 510(k) 2026
- DBLG2Diabeloop · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.